110 results
Page 3 of 6
8-K
EX-99.1
zwinyu
27 Oct 20
Proposed ARTeSYN acquisition adds gold standard single-use downstream bioprocessing systems
4:17pm
8-K
EX-99.1
lgk60rirye2zyr3hlzh7
30 Jul 20
Repligen Reports Second Quarter 2020 Financial Results
7:50am
8-K
EX-99.1
7x8t 1d1c
29 Jun 20
Repligen Announces Agreement to Acquire Engineered Molding Technology
4:02pm
8-K
EX-99.1
w7bfz914afae
15 Jun 20
Repligen Appoints Carrie Eglinton Manner to Board of Directors
7:36am
8-K
EX-99.1
yoiy27lxmmzrr17w3
6 May 20
Repligen Reports First Quarter 2020 Financial Results
7:51am
8-K
EX-99.1
v41ozc51449aiuimny
27 Feb 20
Repligen Appoints Rohin Mhatre, Ph.D. to Board of Directors
7:43am
8-K
EX-99.1
oiq27m8
20 Feb 20
Repligen Reports Fourth Quarter and Full Year 2019 Financial Results
8:05am
8-K
EX-99.1
yhmm5rb
31 Oct 19
Repligen Reports Third Quarter 2019 Financial Results and Updates Full Year 2019 Financial Guidance
8:04am
8-K
EX-99.1
ljuk8
1 Aug 19
Results of Operations and Financial Condition
8:08am
8-K
EX-99.1
maxmxyxof1uvskorw0g
22 Jul 19
Entry into a Material Definitive Agreement
5:09pm
8-K
EX-99.1
bee35
18 Jul 19
Repligen Corporation Announces Proposed Public Offerings of $100 million of Common Stock and $250 million of Convertible Senior Notes
4:02pm
8-K
EX-99.2
dkzjhvmnse95x
18 Jul 19
Repligen Corporation Announces Proposed Public Offerings of $100 million of Common Stock and $250 million of Convertible Senior Notes
4:02pm
424B5
irffv2
17 Jul 19
Prospectus supplement for primary offering
5:13pm
424B5
0qiu clsw1
17 Jul 19
Prospectus supplement for primary offering
5:09pm
424B5
o2alrh1qav5ci016ux
15 Jul 19
Prospectus supplement for primary offering
4:11pm
424B5
9136o
15 Jul 19
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
r9ka9iwycfwdbx16xhm
9 May 19
Results of Operations and Financial Condition
7:55am
8-K
EX-99.2
m9qru
1 May 19
Repligen Corporation Announces Proposed Public Offering
4:11pm
8-K
EX-99.1
fw42q8hc
1 May 19
Repligen Corporation Announces Proposed Public Offering
4:11pm